REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27/12/2025
Voltar para busca
Dado oficial do USPTO
QUIDEL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
QUIDEL
ST13
US500000086445815Classe
1, 5, 9, 10, 42
Pedido
86445815
Registro
5110309
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
28/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 42
Data de depósito
05/11/2014
Data de registro
27/12/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/06/2023
Última transação
28/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
30/01/1984
Primeiro uso no comércio
30/01/1984
Código do desenho
4
Tipo de titular
03
Localização do titular
RARITAN, NJ
Examinador
MONINGHOFF,KIM TERESA
Unidade examinadora
M40
Localização atual
TMO LAW OFFICE 113
Titulares e representantes
Titulares
ORTHO-CLINICAL DIAGNOSTICS, INC.
Q. C. (pessoa física)
Representantes
Alexis Crawford Douglas K&L Gates LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic reagent test kits comprised of monoclonal antibodiesbuffersreagents for clinical or medical laboratoryscientific or research use; diagnostic reagent test kits comprising detection and identification staining reagentsassociated quality control reagentscustomized microscopy slidesfor clinical laboratory use
Classe 5
In vitro medical diagnostic test kits for clinicalprofessionalmedical or consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring conditions and diagnosing disease; chemicalbiochemical and biological preparations for medical use in cassette formfor use in measuringtesting and analyzing blood and other bodily fluids; chemical reagents in cassette form for medical purposesfor use in connection with diagnostic test kits for the detection of a wide variety of diseasesconditionsdisorders; diagnostic reagent test kits comprising detection and identification staining reagentsassociated quality control reagentscustomized microscopy slidesfor medical and clinical use
Classe 9
Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens; clinical laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; automated fluorescent-based microscopy system comprising light-emitting diodes (LED)objective lensdigital camera charge-coupled device (CCD)motorized slide carrierdiagnostic software for data reduction; wireless routers; gateway routers in the nature of computer control hardware; computer software for capturingorganizingreportingmanagement of medical information and data
Classe 10
Devices in the nature of glass slidescupsbags for the collection of bodily excretions and fluids from humans for medical diagnostic purposes; devices in the nature of glass slidescupsbags and test components in the nature of medical testing devices sold as a kit for the collectionpreservation and shipment of bodily excretions and fluids from humans for clinical medical diagnostic purposes; medical diagnostic apparatus comprised of an optics windowa port for a reagent testan illuminating devicespecifically adapted for reading in vitro medical test results; medical diagnostic analyzers for measuringtesting and analyzing blood and other bodily fluids
Classe 42
Providing a website portal featuring technology that allows users to access medical information and data; providing temporary use of on-line non-downloadable cloud computing software for capturingorganizingreportingremote management of medical information and data
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/09/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/01/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
13/06/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
13/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/01/2023
E815
TEAS SECTION 8 & 15 RECEIVED
12/12/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
22/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/05/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/04/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/04/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/04/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
27/12/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23/11/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
22/11/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/10/2016
GNRT
NON-FINAL ACTION E-MAILED
17/10/2016
CNRT
SU - NON-FINAL ACTION - WRITTEN
17/10/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
15/10/2016
IUAF
USE AMENDMENT FILED
05/10/2016
EISU
TEAS STATEMENT OF USE RECEIVED
05/10/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/06/2016
EX2G
SOU EXTENSION 2 GRANTED
24/06/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
22/06/2016
EXT2
SOU EXTENSION 2 FILED
23/05/2016
EEXT
SOU TEAS EXTENSION RECEIVED
23/05/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/12/2015
EX1G
SOU EXTENSION 1 GRANTED
18/12/2015
EXT1
SOU EXTENSION 1 FILED
18/12/2015
EEXT
SOU TEAS EXTENSION RECEIVED
18/12/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30/06/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2015
PUBO
PUBLISHED FOR OPPOSITION
05/05/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/04/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/03/2015
ALIE
ASSIGNED TO LIE
23/03/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/03/2015
DOCK
ASSIGNED TO EXAMINER
25/02/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/11/2014
NWAP
NEW APPLICATION ENTERED
08/11/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QUIDEL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.